Papillomvirusinfektionen beim Hund: eine Übersicht

Zusammenfassung:

Papillomvirusinfektionen sind bei vielen Tierarten und dem Menschen bekannt. Bei Hunden und wild lebenden Kaniden führt eine Infektion mit dem „Virus der kaninen oralen Papillomatose“ (COPV) zur einer Erkrankung, die gewöhnlich durch die Ausbildung von einzelnen oder multiplen blumenkohlartigen Papillomen im Bereich der Mundhöhle gekennzeichnet ist. Insbesondere bei immunsupprimierten Tieren werden auch schwere Krankheitsverläufe mit Ausbreitung der Läsionen auf die gesamte Körperoberfläche beobachtet. Die Persistenz der Läsionen stellt eine weitere Komplikation dar. Es gibt Hinweise darauf, dass neben COPV weitere kanine Papillomvirustypen existieren. Die vorliegende Arbeit gibt einen Überblick über die besonderen Eigenschaften von Papillomviren sowie über Klinik und Diagnostik kaniner Papillomvirusinfektionen.

Summary:

Papillomavirus infections have been detected in various animal species and in humans. In dogs and wild canids, an infection with canine oral papillomavirus (COPV) leads to a disease characterized by single or multiple cauliflower-like papillomas in the oral cavity. Severe disease with lesions spread throughout the whole body has been observed mainly in immunosuppressed animals. Persistence of papillomas may also occur. There is evidence that there are types of canine papillomavirus different from COPV. In this communication, a current overview is given summarising the specific characteristics of papillomaviruses as well as clinical findings and diagnostics of canine papillomavirus infections.

Schlüsselwörter:

Papillomviren - kanine orale Papillomatose - COPV - Hund

Key words:

Papillomaviruses - canine oral papillomatosis - COPV - dog

• Literatur

• 1 Agut M, Bayo M, Larrondo J, Calvo MA. Autovaccination as a treatment in canine papillomavirus dermatological disease: a study of nine cases. Biomedical Letters 1996; 54: 23-26.
• 2 Amtmann E, Müller H, Sauer G. Equine connective tissue tumors contain unintegrated bovine papilloma virus DNA. J Virol 1980; 35: 962-964.
• 3 Amtmann E, Sauer G. Bovine papilloma virus transcription: polyadenylated RNA species and assessment of the direction of transcription. J Virol 1982; 43: 59-66.
• 4 Baker CC, Howley PM. Differential promotor utilization by the papillomavirus in transformed cells and productively infected wart tissues. EMBO J 1987; 6: 1027-1035.
• 5 Belkin VP. Ocular lesions in canine oral papillomatosis (a case report). Vet Med Small Anim Clin 1979; 74: 1520-1527.
• 6 Bell JA, Sundberg JP, Ghim SJ, Newsome J, Jenson AB, Schlegel R. A formalin- inactivated vaccine protects against mucosal papillomavirus infection: a canine model. Pathobiology 1994; 62: 194-198.
• 7 Bredal WP, Thoresen SI, Rimstad E, Aleksandersen M, Nafstad PHJ. Diagnosis and clinical course of canine oral papillomavirus infection. J Small Anim Pract 1996; 37: 138-142.
• 8 Bregman CL, Hirth RS, Sundberg JP, Christensen EF. Cutaneous neoplasms in dogs associated with canine oral papillomavirus vaccine. Vet Pathol 1987; 24: 477-487.
• 9 Campbell KL, Sundberg JP, Goldschmidt MH, Knupp C, Reichmann ME. Cutaneous inverted papillomas in dogs. Vet Pathol 1988; 25: 67-71.
• 10 Campo MS. Animal models of papillomavirus pathogenesis. Virus Res 2002; 89: 249-261.
• 11 Chambers G, Ellsmore VA, O’Brien PM, Reid SWJ, Love S, Campo MS, Nasir L. Association of bovine papillomavirus with the equine sarcoid. J Gen Virol 2003; 84: 1055-1062.
• 12 Chambers VC, Evans CA, Weiser RS. Canine oral papillomatosis II. immunologic aspects of the disease. Cancer Res 1960; 20: 1083-1093.
• 13 Chambers VC, Evans CA. Canine oral papillomatosis I. Virus assay and observations on the various stages of the experimental infection. Cancer Res 1959; 19: 1188-1195.
• 14 Cierpisz J, Kielbowicz Z, Krol J. The use of autovaccine in a typical case of papillomatosis in a dog. Zycie Weterynaryjne 1993; 68: 205-206.
• 15 Debey BM, Bagladi-Swanson M, Kapil S, Oehme FW. Digital papillomatosis in a confined beagle. J Vet Diagn Invest 2001; 13: 346-348.
• 16 Delius H, Van Ranst MA, Jenson AB, Zur Hausen H, Sundberg JP. Canine oral papillomavirus genomic sequence: a unique 1.5-kb intervening sequence between the E2 and L2 open reading frames. Virology 1994; 204: 447-452.
• 17 DeMonbreun WA, Goodpasture EW. Infectious oral papillomatosis of dogs. Am J Pathol 1932; 8: 43-56.
• 18 de Villiers EM, Bernhard HU, Broker T, Delius H, zur Hausen H. Papillomaviridae. In: Virus Taxonomy, VIIIth Report of the international Commitee for the Taxonomy of Viruses Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA. London: Elsevier/Academic Press; 2005: 239-253.
• 19 Douglas RL, Howley PM. Papillomaviruses. In: Fields Virology 4th ed.. Knipe DM. et al eds Philadelphia: Lippincott Williams & Wilkins; 2001: 2231-2264.
• 20 Favre M, Breitburd F, Croissant O, Orth G. Structural polypeptides of rabbit, bovine and human papillomaviruses. J Virol 1975; 15: 1239-1247.
• 21 Gaskell RM, Bennett M. Infektionskrankheiten bei Hund und Katze. Hamburg: Parey; 1999
• 22 Gilbert DM, Cohen SN. Bovine papilloma virus plasmids replicate randomly in mouse fibroblasts throughout S phase of the cell cycle. Cell 1987; 50: 59-68.
• 23 Greene CE. Environmental survival of certain microorganisms and some effective bactericidal agents. In: Infectious Diseases of the Dog and Cat 2nd ed.. Greene CE. ed Philadelphia: Saunders; 1998. Appendix 9
• 24 Greig AS, Charlton KM. Electron microscopy of the virus of oral papillomatosis in the coyote. J Wildl Dis 1973; 9: 359-361.
• 25 Howley PM, Douglas RL. Papillomaviruses and their replication. In: Fields Virology 4th ed.. Knipe DM. et al eds Philadelphia: Lippincott Williams & Wilkins; 2001: 2197-2230.
• 26 International Agency for Research on Cancer (IARC). The current status of development of prophylactic vaccines against human papillomavirus infection World Health Organization: Report of a technical meeting Geneva: 16.-18.02 1999: 1-22.
• 27 Jacobson ER, Gaskin JM. Clubb Schriftleiter. Papilloma-like virus infection in Bolivian side-neck turtles. J Am Vet Assoc 1982; 175: 937-940.
• 28 Le Net J-L, Orth G, Sundberg JP, Cassonnet P, Poisson L, Masson M-T, George C, Longeart L. Multiple pigmented cutaneous papules associated with a novel canine papillomavirus in an immunosuppressed dog. Vet Pathol 1997; 34: 8-14.
• 29 Kuntsi-Vaatovaara H, Verstraete FJM, Newsome JT, Yuan H. Resolution of persistent oral papillomatosis in a dog after treatment with recombinant canine oral papillomavirus vaccine. Vet Comp Oncol 2003; 1: 57-63.
• 30 M’Fadyean J, Hobday F. Note on the experimental transmission of warts in the dog. J Comp Pathol Therap 1898; 11: 341-344.
• 31 Moore RA, Nicholls PK, Santos EB, Gough GW, Stanley MA. Absence of canine oral papillomavirus DNA following prophylactic L1 particle-mediated immunotherapeutic delivery vaccination. J Gen Virol 2002; 83: 2299-2301.
• 32 Müller H. Papillomatosen des Rindes und ihre Beziehungen zum equinen Sarkoid. Tierärztl Prax 1991; 19: 39-43.
• 33 Narama I, Ozaki K, Maeda H, Ohta A. Cutaneous papilloma with viral replication in an old dog. J Vet Med Sci 1992; 54: 387-389.
• 34 Nicholls PK, Klaunberg BA, Moore RA, Santos EB, Parry NR, Gough GW, Stanley MA. Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection. Virology 1999; 265: 365-374.
• 35 Nicholls PK, Stanley MA. Canine papillomavirus – a centenary review. J Comp Pathol 1999; 120: 219-233.
• 36 Penberthy J. Contagious warty tumours in dogs. J Comp Pathol Therap 1898; 11: 363-5.
• 37 Pfister H, Gissman L, zur Hausen H. Partial characterization of proteins of human papillomaviruses (HPV) 1-3 Virology. 1977; 83: 131-137.
• 38 Ragland WH, Keown GH, Spencer GR. Equine sarcoid. Equine Vet J 1970; 2: 2-11.
• 39 Roden RB, Lowy DR, Schiller JT. Papillomavirus is resistant to desiccation. J Infect Dis 1997; 176: 1076-1079.
• 40 Rolle M, Mayr A. Medizinische Mikrobiologie, Infektions- und Seuchenlehre, 7. Aufl. Stuttgart: Enke; 2002: 115
• 41 Schwegler K, Walter JH, Rudolph R. Epithelial neoplasms of the skin, the cutaneous mucosa and the transitional epithelium in dogs: an immunolocalization study for papillomavirus antigen. Zentralbl Veterinärmed A 1997; 44: 115-123.
• 42 Shimada A, Shinya K, Awakura T, Narama I, Maeda H, Umemura T. Cutaneous papillomatosis associated with papillomavirus infection in a dog. J Comp Pathol 1993; 108: 103-107.
• 43 Steinberg BM, Meade R, Kalinowski S, Abramson AL. Abnormal differentiation of human papillomavirus-induced laryngeal papillomas. Arch Otolaryngol Head Neck Surg 1990; 116: 1167-1171.
• 44 Sundberg JP, Reszka AA, Williams ES, Reichmann ME. An oral papillomavirus that infected one coyote and three dogs. Vet Pathol 1991; 28: 87-88.
• 45 Sundberg JP, Smith EK, Herron AJ, Jenson AB, Burk RD, Van Ranst M. Involvement of canine oral papillomavirus in generalized oral and cutaneous verrucosis in a Chinese Shar Pei dog. Vet Pathol 1994; 31: 183-187.
• 46 Sundberg JP, Van Ranst M, Montali R, Homer BL, Miller WH, Rowland PH, Scott DW, England JJ, Dunstan RW, Mikaelian I, Jenson AB. Feline papillomas and papillomaviruses. Vet Pathol 2000; 37: 1-10.
• 47 Sundberg JP. Canine papillomaviruses. In: Veterinary Diagnostic Virology: A Pactitioner’s Guide Castro AE, Heuschele WP. eds St. Louis: Mosby Year Book; 1992: 148-150.
• 48 Sundberg JP, O’Banion MK, Schmidt-Didier E, Reichmann ME. Cloning and characterization of a canine oral papillomavirus. Am J Vet Res 1986; 47: 1142-1144.
• 49 Tanabe C, Kano R, Nagata M, Nakamura Y, Watanabe S, Hasegawa A. Molecular characteristics of cutaneous papillomavirus from the canine pigmented epidermal nevus. J Vet Med Sci 2000; 62: 1189-1192.
• 50 Teifke JP, Löhr CV, Shirasawa H. Detection of canine oral papillomavirus- DNA in canine oral squamous cell carcinomas and p53 overexpressing skin papillomas of the dog using the polymerase chain reaction and non-radioactive in situ-hybridization. Vet Microbiol 1998; 60: 119-130.
• 51 Wutzler P, Sauerbrei A. Virucidal efficacy of a combination of 0.2% peracetic acid and 80% (v/v) ethanol (PAA-ethanol) as a potential hand disinfectant. J Hosp Inf 2000; 46: 304-308.
• 52 Zaugg N, Nespeca G, Hauser B, Ackermann M, Favrot C. Detection of novel papillomaviruses in canine mucosal, cutaneous and in situ squamous cell carcinomas. Vet Dermatol 2005; 16: 290-298.